These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 32390175)

  • 1. Do the circulating Pre-S/S quasispecies influence hepatitis B virus surface antigen levels in the HBeAg negative phase of HBV infection?
    Cavallone D; Ricco G; Oliveri F; Colombatto P; Moriconi F; Coco B; Romagnoli V; Salvati A; Surace L; Bonino F; Brunetto MR
    Aliment Pharmacol Ther; 2020 Jun; 51(12):1406-1416. PubMed ID: 32390175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive value of HBsAg quantification for determining the clinical course of genotype C HBeAg-negative carriers.
    Park H; Lee JM; Seo JH; Kim HS; Ahn SH; Kim DY; Han KH; Chon CY; Park JY
    Liver Int; 2012 May; 32(5):796-802. PubMed ID: 22128792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcome of inactive and active, low viraemic HBeAg-negative-hepatitis B virus infection: Benign course towards HBsAg clearance.
    Oliveri F; Surace L; Cavallone D; Colombatto P; Ricco G; Salvati N; Coco B; Romagnoli V; Gattai R; Salvati A; Moriconi F; Yuan Q; Bonino F; Brunetto MR
    Liver Int; 2017 Nov; 37(11):1622-1631. PubMed ID: 28296013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B surface antigen serum levels help to distinguish active from inactive hepatitis B virus genotype D carriers.
    Brunetto MR; Oliveri F; Colombatto P; Moriconi F; Ciccorossi P; Coco B; Romagnoli V; Cherubini B; Moscato G; Maina AM; Cavallone D; Bonino F
    Gastroenterology; 2010 Aug; 139(2):483-90. PubMed ID: 20451520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of hepatitis B surface antigen (HBsAg) in identifying true inactive HBsAg carriers infected with genotype C hepatitis B virus.
    Yim SY; Um SH; Jung JY; Seo YS; Yim HJ; Ryu HS; Chun HJ; Jeen YT; Kim CD; Keum B; Lee HS
    J Clin Gastroenterol; 2014 Feb; 48(2):166-71. PubMed ID: 24045280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic hepatitis B in pregnant women: is hepatitis B surface antigen quantification useful for viral load prediction?
    Fujiko M; Chalid MT; Turyadi ; Ie SI; Maghfira ; Syafri ; Wahyuni R; Roni M; Patellongi I; Massi MN; Muljono DH
    Int J Infect Dis; 2015 Dec; 41():83-9. PubMed ID: 26571304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-viral therapy can be delayed or avoided in a significant proportion of HBeAg-negative Caucasian patients in the Grey Zone.
    Bonacci M; Lens S; Mariño Z; Londoño MC; Rodríguez-Tajes S; Mas A; García-López M; Pérez-Del-Pulgar S; Sánchez-Tapias JM; Forns X
    Aliment Pharmacol Ther; 2018 May; 47(10):1397-1408. PubMed ID: 29577350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of disease reactivation in asymptomatic hepatitis B e antigen-negative chronic hepatitis B patients using baseline serum measurements of HBsAg and HBV-DNA.
    Martinot-Peignoux M; Lapalus M; Laouénan C; Lada O; Netto-Cardoso AC; Boyer N; Ripault MP; Carvalho-Filho R; Asselah T; Marcellin P
    J Clin Virol; 2013 Oct; 58(2):401-7. PubMed ID: 24004660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B surface antigen level complements viral load in predicting viral reactivation in spontaneous HBeAg seroconverters.
    Tseng TC; Liu CJ; Yang WT; Chen CL; Yang HC; Su TH; Wang CC; Kuo SF; Liu CH; Chen PJ; Chen DS; Kao JH
    J Gastroenterol Hepatol; 2014 Jun; 29(6):1242-9. PubMed ID: 24384028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in the serum level of hepatitis B virus (HBV) surface antigen over the natural course of HBV infection.
    Matsumoto A; Tanaka E; Morita S; Yoshizawa K; Umemura T; Joshita S
    J Gastroenterol; 2012 Sep; 47(9):1006-13. PubMed ID: 22370816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].
    Sayan M; Mutlu B; Erdoğan S; Meriç M; Willke A
    Mikrobiyol Bul; 2007 Jan; 41(1):87-93. PubMed ID: 17427556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B surface antigen levels after hepatitis B e-antigen seroclearance: a longitudinal follow-up study.
    Fung J; Seto WK; Wong DK; Lai CL; Yuen MF
    Liver Int; 2015 Mar; 35(3):854-9. PubMed ID: 24840542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occult hepatitis B virus infection with positive hepatitis B e antigen.
    Han Z; Liu Y; Pan J; Bi Y; Liu J; Zhou YH
    Clin Chim Acta; 2015 Jan; 438():266-8. PubMed ID: 25218700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum hepatitis B core-related antigen is more accurate than hepatitis B surface antigen to identify inactive carriers, regardless of hepatitis B virus genotype.
    Riveiro-Barciela M; Bes M; Rodríguez-Frías F; Tabernero D; Ruiz A; Casillas R; Vidal-González J; Homs M; Nieto L; Sauleda S; Esteban R; Buti M
    Clin Microbiol Infect; 2017 Nov; 23(11):860-867. PubMed ID: 28288829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher lifetime chance of spontaneous surface antigen loss in hepatitis B carriers with genotype C infection.
    Tseng TC; Liu CJ; Chen CL; Yang WT; Yang HC; Su TH; Wang CC; Kuo SF; Liu CH; Chen PJ; Chen DS; Kao JH
    Aliment Pharmacol Ther; 2015 May; 41(10):949-60. PubMed ID: 25809540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal change of HBsAg in HBeAg-negative patients with genotype B or C infection.
    Su TH; Liu CJ; Tseng TC; Liu CH; Yang HC; Chen CL; Chen PJ; Kao JH; Chen DS
    PLoS One; 2013; 8(2):e55916. PubMed ID: 23437072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of hepatitis B viraemia levels in patients with HBeAg-negative chronic hepatitis B virus infection.
    Atay AE; Seven G; Yalcin K; Pasa S; Degertekin H
    J Int Med Res; 2012; 40(5):1891-6. PubMed ID: 23206472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low level hepatitis B viremia detected by polymerase chain reaction accompanies the absence of HBe antigenemia and hepatitis in hepatitis B virus carriers.
    Niitsuma H; Ishii M; Miura M; Kobayashi K; Toyota T
    Am J Gastroenterol; 1997 Jan; 92(1):119-23. PubMed ID: 8995950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Characteristics and Correlation Analysis of Subjects with Chronic Hepatitis B Virus (HBV) Infection and Sustained Low Levels of Hepatitis B Surface Antigen (HBsAg).
    Cheng J; Dai Y; Yan L; Zhou H; Xu X; Sun C; Wang Z
    Med Sci Monit; 2018 Mar; 24():1826-1835. PubMed ID: 29593208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New assays for quantitative determination of viral markers in management of chronic hepatitis B virus infection.
    Zoulim F; Mimms L; Floreani M; Pichoud C; Chemin I; Kay A; Vitvitski L; Trepo C
    J Clin Microbiol; 1992 May; 30(5):1111-9. PubMed ID: 1583107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.